Guangdong Moltech Pharma Co. Ltd.
Records under this name other than patents Guangdong Moltech Pharma Co. Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 2 of 2 · Back to Guangdong Moltech Pharma Co. Ltd.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,487,058 | Cyclopropyl unsaturated quinoline compound used as leukotriene receptor antagonist and applications thereof Lapsed on the fee record Ended Nov 26, 2023 · From the USPTO record | Lapsed on the fee record | Ended Nov 26, 2023 | From the USPTO record |
| US 10,315,997 | Cyclopropyl unsaturated quinoline compound used as leukotriene receptor antagonist and applications thereof Lapsed on the fee record Ended Jun 11, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jun 11, 2023 | From the USPTO record |